SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-034777
Filing Date
2022-10-20
Accepted
2022-10-20 17:21:53
Documents
12
Period of Report
2022-10-14
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K scyx-8k_20221014.htm   iXBRL 8-K 55828
  Complete submission text file 0001564590-22-034777.txt   187208

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA scyx-20221014.xsd EX-101.SCH 5693
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20221014_lab.xml EX-101.LAB 19431
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20221014_pre.xml EX-101.PRE 11582
6 EXTRACTED XBRL INSTANCE DOCUMENT scyx-8k_20221014_htm.xml XML 3540
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36365 | Film No.: 221321731
SIC: 2834 Pharmaceutical Preparations